Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PYXS | ASRT | VRCA | ||
| Company | Pyxis Oncology Inc | Assertio Therapeutics Inc | Verrica Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.4400 | 13.99 | 4.82 | ||
| High | 1.4700 | 16.50 | 5.20 | ||
| Low | 1.3500 | 13.96 | 4.25 | ||
| Latest | 1.3600 | 16.71 | 4.52 | ||
| Change | -0.0600 | +2.71 | -0.33 | ||
| % Change | -4.23% | +19.36% | -6.80% | ||
| Volume | 525,003 | 296,091 | 120,346 | ||
| 20-Day Average Volume | 335,372 | 82,039 | 143,985 | ||
| Previous Close | 1.4200 | 14.00 | 4.85 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.4975 | 12.40 | 5.59 | ||
| 20-Day Raw Stochastic | 18.92% | 100.00% | 6.55% | ||
| 20-Day Relative Strength | 42.66 | 76.50 | 33.84 | ||
| Weighted Alpha | +60.33 | +63.35 | -67.78 | ||
| Today's Opinion | 80% Sell | 88% Buy | 56% Sell | ||
| Previous Opinion | 80% Sell | 80% Buy | 40% Sell | ||
| Last Month's Opinion | 80% Sell | 56% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.58% since 03/17/26 | +30.00% since 03/17/26 | -29.95% since 03/17/26 | ||
| Low | 1.3500 on 03/24/26 | 12.41 on 03/18/26 | 4.27 on 03/24/26 | ||
| High | 1.7000 on 03/18/26 | 16.25 on 03/24/26 | 6.39 on 03/18/26 | ||
| 1-Month | |||||
| %Chg | -5.41% since 02/24/26 | +36.10% since 02/24/26 | -20.93% since 02/24/26 | ||
| Low | 1.3300 on 03/06/26 | 11.05 on 03/03/26 | 4.27 on 03/24/26 | ||
| High | 1.7000 on 03/18/26 | 16.25 on 03/24/26 | 6.56 on 03/12/26 | ||
| 3-Month | |||||
| %Chg | +26.13% since 12/24/25 | +64.17% since 12/24/25 | -46.94% since 12/24/25 | ||
| Low | 1.0300 on 12/26/25 | 8.61 on 12/31/25 | 4.27 on 03/24/26 | ||
| High | 2.1650 on 01/12/26 | 16.25 on 03/24/26 | 9.02 on 12/30/25 | ||
| 6-Month | |||||
| %Chg | -35.48% since 09/24/25 | +13.57% since 09/24/25 | +6.00% since 09/24/25 | ||
| Low | 1.0300 on 12/26/25 | 8.61 on 12/31/25 | 3.28 on 11/04/25 | ||
| High | 5.5500 on 11/26/25 | 16.25 on 03/24/26 | 9.82 on 11/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 88,415 | 90,233 | 83,318 | ||
| Shares Outstanding, K | 62,264 | 6,445 | 17,179 | ||
| Annual Sales | 16,150,000 | 118,710,000 | 35,580,000 | ||
| Annual Net Income | -77,330,000 | -30,380,000 | -17,890,000 | ||
| Last Quarter Sales | 2,820,000 | 13,540,000 | 5,090,000 | ||
| Last Quarter Net Income | -18,350,000 | -11,930,000 | -8,070,000 | ||
| 60-Month Beta | 1.45 | 0.73 | 1.47 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 11/03/25 | -1.86 on 03/16/26 | -0.51 on 03/11/26 | ||
| Latest Earnings Date | 03/24/26 | 05/11/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||